Treo Ventures logo

Treo Ventures

North America, California, United States, Santa Clara

Description

We focus on medical device and digital health innovation that can significantly impact human life.

Investor Profile

Treo Ventures has made 10 investments, with 4 in the past 12 months and 60% as lead.

Stage Focus

  • Series A (40%)
  • Series C (20%)
  • Series B (20%)
  • Private Equity (10%)
  • Series D (10%)

Country Focus

  • United States (100%)

Industry Focus

  • Medical Device
  • Health Care
  • Medical
  • Therapeutics
  • Machinery Manufacturing
  • Product Design
  • Clinical Trials
  • Biotechnology
  • Health Diagnostics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Treo Ventures frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 2
Vensana Capital
North America, Minnesota, United States, Minneapolis
Co-Investments: 2
Hatteras Venture Partners
North America, North Carolina, United States, Durham
Co-Investments: 2
Vertex Ventures HC
North America, California, United States, Palo Alto
Co-Investments: 2
LivaNova
Europe, England, United Kingdom, London
Co-Investments: 2
Amzak Health Investors
North America, New York, United States, New York
Co-Investments: 2
Aperture Venture Partners
North America, New York, United States, New York
Co-Investments: 2
U.S. Venture Partners
North America, California, United States, Menlo Park
Co-Investments: 2
Action Potential Venture Capital
North America, Massachusetts, United States, Cambridge
Co-Investments: 3
Windham Venture Partners
North America, New York, United States, New York
Co-Investments: 2

What are some of recent deals done by Treo Ventures?

SecondWave Systems

Minneapolis, Minnesota, United States

SecondWave Systems is an ultrasound stimulation platform.

Health Care
Series AApr 8, 2025
Amount Raised: $7,000,000
InterVene

South San Francisco, California, United States

InterVene is a medical device company that treats severe venous disease in the legs.

Health CareMedicalMedical Device
Series AOct 7, 2024
Amount Raised: $13,000,000
ShiraTronics

Minneapolis, Minnesota, United States

ShiraTronics develops neuromodulation technology to combat debilitating chronic migraine.

Clinical TrialsHealth CareMedical Device
Series BSep 30, 2024
Amount Raised: $66,000,000
NeuSpera Medical

San Jose, California, United States

NeuSpera Medical is a manufacturing firm that designs, manufactures, and sells implantable neuromodulation medical devices.

Machinery ManufacturingMedical DeviceProduct Design
Series DJul 15, 2024
Amount Raised: $23,000,000
iVEAcare

Minneapolis, Minnesota, United States

iVEAcare develops innovative neuromodulation therapy to treat unmet clinical needs.

Health CareMedical Device
Series AApr 22, 2024
Amount Raised: $27,500,000
Noctrix Health

San Francisco, California, United States

Noctrix Health is an early-stage medical device company that focuses on developing a revolutionary therapy for a chronic illness.

Health CareMedical DeviceTherapeutics
Series CJan 16, 2024
Amount Raised: $40,000,000
NeuSpera Medical

San Jose, California, United States

NeuSpera Medical is a manufacturing firm that designs, manufactures, and sells implantable neuromodulation medical devices.

Machinery ManufacturingMedical DeviceProduct Design
Series CJul 20, 2021
Amount Raised: $65,000,000
Noctrix Health

San Francisco, California, United States

Noctrix Health is an early-stage medical device company that focuses on developing a revolutionary therapy for a chronic illness.

Health CareMedical DeviceTherapeutics
Series BJan 11, 2021
Amount Raised: $17,000,000
CVRx

Minneapolis, Minnesota, United States

CVRx is a medical device company developing implantable technology for the treatment of high blood pressure.

BiotechnologyHealth CareHealth DiagnosticsMedicalMedical Device
Private EquityJul 7, 2020
Amount Raised: $50,000,000
ShiraTronics

Minneapolis, Minnesota, United States

ShiraTronics develops neuromodulation technology to combat debilitating chronic migraine.

Clinical TrialsHealth CareMedical Device
Series AOct 24, 2019
Amount Raised: $41,689,951